Planned enrollment increased by 47 participants
Before: 460 participants (planned). After: 507 participants (planned).
Study sponsor: ImmunityBio, Inc. · IBRX
Primary completion is the date data collection ends for the main study measures, not when results are published.
Before: 460 participants (planned). After: 507 participants (planned).